Seth Martin, MD, MHS

The role of aspirin in primary prevention of CV disease changed for good with results from 3 pivotal trials. Do you recall results and recommendations? Find out.

The 2019 ACC/AHA guidelines on the primary prevention of cardiovascular disease could change your clinical practice. Try these 9 questions to find out how.

The European and American guidelines on dyslipidemia management overlap but also diverge in critical ways. A Johns Hopkins cardiologist highlights similarities and differences.

Test your knowledge of the key elements and outcomes of the highly buzzed about REDUCE-IT trial with this 5-question quiz.

Eighty percent of all cardiovascular events are preventable. The ACC/AHA 2019 guidelines are a single source of best practices to help achieve that goal. Review them here, at-a-glance.

What approach is now AHA/ACC guideline-recommended for a patient with primary hypercholesterolemia, with an LDL-C of 192 mg/dL? Take Quiz #3.

How will changes in the AHA/ACC update to the 2013 guidelines help optimize care for patients with ASCVD? Try part 2 of our 3-part quiz and find out.

What's new and what's not in the AHA/ACC 2018 update to the 2013 lipid management guidelines? Try part I of our 3-part quiz and find out.

To Rx or not to Rx aspirin - is one of our 8 questions based on new research that highlights costs vs benefits of aspirin therapy.